Tefron Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
For the nine months, sales was USD 181.63 million compared to USD 159.67 million a year ago. Net income was USD 8.19 million compared to USD 5.36 million a year ago. Basic earnings per share from continuing operations was USD 0.66 compared to USD 0.44 a year ago. Diluted earnings per share from continuing operations was USD 0.64 compared to USD 0.41 a year ago.